Cargando…
Malignancies, Particularly B-Cell Lymphomas, Are a Frequent Cause of Mortality in Human Immunodeficiency Virus-1 Patients Despite Highly Active Antiretroviral Therapy
Human immunodeficiency virus (HIV)-1-infected individuals are affected by diseases at rates above those of their HIV-negative peers despite the increased life expectancy of the highly active antiretroviral therapy era. We followed a cohort of approximately 2000 HIV-1-infected patients for 5 years. T...
Autores principales: | Griffin, Daniel O., Metzger, Michael, Poeth, Kaitlin, Deng, Kathy, Dharsee, Arif, Rico, Juan Carlos, McGowan, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630453/ https://www.ncbi.nlm.nih.gov/pubmed/26566539 http://dx.doi.org/10.1093/ofid/ofv147 |
Ejemplares similares
-
Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic Acid
por: Stella-Ascariz, Natalia, et al.
Publicado: (2016) -
CD4 Response Up to 5 Years After Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in Latin America and the Caribbean
por: Luz, Paula M., et al.
Publicado: (2015) -
135 HIV-associated immunodeficiency despite potent antiretroviral therapy with CD4 T cell reconstitution
por: Poonia, Bhawna, et al.
Publicado: (2014) -
Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy
por: Weiss, Julian J, et al.
Publicado: (2021) -
The Cost of Not Retesting: Human Immunodeficiency Virus Misdiagnosis in the Antiretroviral Therapy “Test-and-Offer” Era
por: Eaton, Jeffrey W., et al.
Publicado: (2017)